At the time of writing, Gilead Sciences, Inc [GILD] stock is trading at $113.2, down -0.32%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GILD shares have gain 4.04% over the last week, with a monthly amount glided 5.60%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer reaffirmed its Outperform rating on March 04, 2025, and elevated its price target to $132. On February 18, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $120 on the stock. DZ Bank upgraded its rating to a Buy but stick to its price target of $108 on February 13, 2025. Morgan Stanley upgraded its rating to a Overweight and raised its price target to $113 on January 10, 2025. In a note dated November 15, 2024, Wolfe Research initiated an Outperform rating and provided a target price of $110 on this stock.
For the past year, the stock price of Gilead Sciences, Inc fluctuated between $71.42 and $119.96. Currently, Wall Street analysts expect the stock to reach $126.4 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $113.2 at the most recent close of the market. An investor can expect a potential return of 11.66% based on the average GILD price forecast.
Analyzing the GILD fundamentals
According to Gilead Sciences, Inc [NASDAQ:GILD], the company’s sales were 28.69B for trailing twelve months, which represents an -0.60% plunge. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.32 and Total Capital is 0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 112.57 points at the first support level, and at 111.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 113.76, and for the 2nd resistance point, it is at 114.33.
Ratios To Look Out For
It is important to note that Gilead Sciences, Inc [NASDAQ:GILD] has a current ratio of 1.37. In addition, the Quick Ratio stands at 1.23 and the Cash Ratio stands at 0.64. Considering the valuation of this stock, the price to sales ratio is 4.91, the price to book ratio is 7.35 and price to earnings (TTM) ratio is 23.80.
Transactions by insiders
Recent insider trading involved Mercier Johanna, Chief Commercial Officer, that happened on Jul 15 ’25 when 3000.0 shares were sold. Chief Financial Officer, Dickinson Andrew D completed a deal on Jul 15 ’25 to sell 2500.0 shares. Meanwhile, Officer JOHANNA MERCIER bought 3000.0 shares on Jul 15 ’25.
